Welcome to our dedicated page for Radnet SEC filings (Ticker: RDNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The RadNet, Inc. (RDNT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a NASDAQ-listed issuer. RadNet files reports and current updates with the U.S. Securities and Exchange Commission in connection with its operations as a national provider of freestanding, fixed-site diagnostic imaging services and as the parent of the DeepHealth digital health division.
Among the filings that investors commonly review are annual reports on Form 10-K and quarterly reports on Form 10-Q, which present information on RadNet’s Imaging Center and Digital Health reportable segments, revenue composition, imaging volumes, liquidity and capital structure. Current reports on Form 8-K are used to disclose specific material events, such as the release of quarterly financial results or the filing of a prospectus supplement under an automatic shelf registration statement. For example, RadNet has filed 8-Ks to furnish press releases detailing financial results for quarters ended June 30, 2025 and September 30, 2025, and to report the filing of a prospectus supplement registering shares of common stock for resale by selling stockholders.
Through this filings page, users can also monitor documents related to securities offerings, including prospectus supplements and associated legal opinions, as well as other disclosures that may affect the company’s capital markets activity. Forms related to insider transactions, such as Form 4, and proxy materials on executive compensation and governance are part of the broader SEC record and can be relevant for understanding management incentives and ownership changes.
Stock Titan enhances access to these filings by pairing real-time updates from the SEC’s EDGAR system with AI-powered summaries that explain key points in plain language. This can help readers interpret lengthy documents such as 10-K and 10-Q reports, understand the implications of 8-K announcements and quickly identify notable items in RadNet’s regulatory history. For anyone analyzing RDNT, the SEC filings page is a central source for official, time-stamped information on the company’s financial condition, segment performance and capital markets activity.
RadNet Inc ownership filing: The Vanguard Group reports 0 shares beneficially owned, representing 0% of Common Stock. The filing states an internal realignment effective January 12, 2026 that disaggregated certain Vanguard subsidiaries and business divisions, which now report separately in reliance on SEC Release No. 34-39538.
The filing is an amendment (Amendment No. 8) documenting that, after the reorganization, Vanguard entities reported here hold no voting or dispositive power over RadNet common shares.
RadNet, Inc. director and Chief Strategy Officer Alma Gregory Sorensen reported multiple transactions in the company’s common stock on March 19, 2026. She executed open‑market sales totaling 15,000 shares at prices reported around $61.84, $62.82, and $63.59, with footnotes noting sale price ranges between $61.38–$62.37 and $62.45–$63.44. She also transferred 7,000 shares as a bona fide charitable donation. Following these transactions, she directly holds 1,201,923 shares of RadNet common stock.
Alma Gregory Sorensen reported recent and proposed transactions in Common Stock. The filing lists sales of 15,000 shares on 03/18/2026 for $932,253.00 and 5,919 shares on 03/16/2026 for $365,335.47. The filing also lists restricted stock vesting entries of 9,756 shares on 03/10/2026, 4,877 shares on 06/01/2025, and 367 shares on 06/01/2022, described as "restricted stock vesting under a registered plan."
RDNT submitted a Form 144 notice for the proposed sale of 5,919 shares of Common Stock.
The shares reflect restricted stock vesting under a registered plan with vesting dates of 01/06/2024 (1,885 shares), 01/08/2025 (1,609 shares) and 03/03/2026 (2,425 shares). The filing lists Morgan Stanley Smith Barney LLC as the broker involved.
RadNet, Inc. director and Chief Strategy Officer Alma Gregory Sorensen reported net sales of 15,000 shares of common stock in open-market transactions. The sales occurred at average prices of $62.12 and $62.72, across multiple trades within disclosed price ranges.
In a separate transaction, 5,919 shares were withheld to cover tax obligations, which is not an open-market sale. After all transactions, Sorensen directly holds 1,223,923 RadNet common shares.
RDNT reported a Rule 144 notice to sell up to 15,000 shares of Common Stock. The filing lists 15,000 shares associated with restricted stock vesting under a registered plan dated 06/01/2025. It also discloses a recent sale of 5,919 shares on 03/16/2026 for $365,335.47.
RadNet, Inc. director and Chief Strategy Officer Alma Gregory Sorensen exercised previously granted employee stock options on March 10, 2026 to acquire 62,964 shares of common stock. These options were originally granted in connection with retention of employment at DeepHealth, Inc., a wholly owned subsidiary of RadNet, with vesting over several years.
Following the exercises, Sorensen directly holds 1,244,842 shares of RadNet common stock. The transactions reflect compensation-related option exercises rather than open-market buying or selling.
RadNet, Inc. reported that executive officer Mital Patel, EVP of Financial Planning and Chief Accounting Officer, acquired 20,667 shares of Common Stock on March 3, 2026 through a grant or award transaction priced at $0.0000 per share.
After this grant or award acquisition, Patel directly held 200,175 shares of RadNet common stock.
RadNet, Inc. reported that EVP and Chief Legal Officer David Jeffrey Katz acquired 19,289 shares of Common Stock on 2026-03-03 through a grant, award, or other acquisition at a stated price of $0.0000 per share. Following this transaction, he directly held 90,866 shares of Common Stock.
RadNet, Inc. reported that Cornelis Wesdorp, Pres & CEO, Digital Health, received a grant of 20,330 shares of Common Stock as of March 3, 2026. The transaction was recorded at a price of $0.0000 per share and classified as a grant, award, or other acquisition.
Following this award, Wesdorp held a total of 73,825 shares of RadNet common stock in direct ownership, as disclosed in the filing.